Hosted by EIC Mikael Angelo Francisco, Ask Theory shines the spotlight on Pinoy scientific brilliance, in a fun and entertaining “kwentuhan” format. Each episode of Ask Theory features a Pinoy scientist from one of the various scientific disciplines. In a very casual conversation, guests explain what they do in simple terms, as well as share their fascinating stories: how they got into science, the challenges they face, what motivates them to pursue their fields, what future scientists from the Philippines can look forward to, and so much more.
Episode 81: Paano Ba Nakahahanap Ng Gamot Mula Sa Dagat?
Dr. Joshua Torres is a conotoxinologist at the Department of Biomedical Sciences of the University of Copenhagen. As a medicinal chemist, he studies the medicinal potential of marine animals and bacteria, mostly from the Philippines.
We talked about cone snails and how they manage to be both dangerous and beneficial to humans, the discovery of the cancer-killing molecule boholamide A, the relationship between studying nature and drug development, the scientific contributions of Filipino scientists who work abroad, a fellowship opportunity for Philippine-based scientists, and more.
How to contact Dr. Joshua:
- Twitter: @yeahhh_wa
- Email: email@example.com
Listen to Ask Theory Episode 81 here:
(Full transcript to follow; watch this page for updates)
The Ask Theory Podcast is available via these platforms — make sure to subscribe, as we’ll be releasing a new episode every week:
Apple Podcasts: https://podcasts.apple.com/ph/podcast/ask-theory/id1550251048
Google Podcasts: https://www.google.com/podcasts?feed=aHR0cHM6Ly9hbmNob3IuZm0vcy80OTAyMWNjMC9wb2RjYXN0L3Jzcw==
Pocket Casts: https://pca.st/gv6jxkki
Music: Hopeful Cinematic Ambient by bdProductions; My Mysterious Planet by Free Music
Author: Mikael Angelo Francisco
Bitten by the science writing bug, Mikael has years of writing and editorial experience under his belt. As the editor-in-chief of FlipScience, Mikael has sworn to help make science more fun and interesting for geeky readers and casual audiences alike.